Page last updated: 2024-08-24

dexamethasone-21-sulfobenzoate and Lymphocytopenia

dexamethasone-21-sulfobenzoate has been researched along with Lymphocytopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
al-Fayoumi, S; Barth, J; Derendorf, H; Hochhaus, G; Hochhaus, R; Möllmann, H; Suarez, S1

Trials

1 trial(s) available for dexamethasone-21-sulfobenzoate and Lymphocytopenia

ArticleYear
Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP).
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Cross-Over Studies; Dexamethasone; Flow Cytometry; Glucocorticoids; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Lymphocytes; Lymphopenia; Male; Metabolic Clearance Rate; Models, Biological; Radioimmunoassay

2001